EUVIMEDEUVIMED entdecken
Crossref

A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy

Ming Li, Dong Zhao, Jianqin Yan, Xiaoheng Fu, Fashun Li, Gecen Liu, Yujiang Fan iD, Yan Liang iD, Xingdong Zhang

ACS Nano · 21.05.2024 · 18 (20) · 12870-12884

DOI: 10.1021/acsnano.4c00227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.05.2024. Verfasst von Ming Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China. Hauptthemen laut MEDLINE: Autophagy, B7-H1 Antigen, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epirubicin (EPI) alone can trigger mildly protective autophagy in residual tumor cells, resulting in an immunosuppressive microenvironment. This accelerates the recurrence of residual tumors and leads to antiprogrammed death ligand 1 (anti-PD-1)/PD-L1 therapy resistance, posing a significant clinical challenge in tumor immunotherapy. The combination of checkpoint inhibitors targeting the PD-1/PD-L1 pathway and amplifying autophagy presents an innovative approach to tumor treatment, which can prevent tumor immune escape and enhance therapeutic recognition. Herein, we aimed to synthesize a redox-triggered autophagy-induced nanoplatform with SA&EA-induced PD-L1 inhibition. The hyaluronic acid (HA) skeleton and arginine segment promoted active nanoplatform targeting, cell uptake, and penetration. The PLGLAG peptide was cleaved by overexpressing matrix metalloproteinase-2 (MMP-2) in the tumor microenvironment, and the PD-L1 inhibitor D-PPA was released to inhibit tumor immune escape. The intense autophagy inducers, STF-62247 and EPI, were released owing to the cleavage of disulfide bonds influenced by the high glutathione (GSH) concentration in tumor cells. The combination of EPI and STF induced apoptosis and autophagic cell death, effectively eliminating a majority of tumor cells. This indicated that the SA&EA nanoplatform has better therapeutic efficacy than the single STF@AHMPP and EPI@AHMPTP groups. This research provided a way to set up a redox-triggered autophagy-induced nanoplatform with PD-L1 inhibition to enhance chemo-immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyB7-H1 AntigenImmunotherapyNanoparticlesAnimalsHumansMiceCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorHyaluronic AcidImmune Checkpoint InhibitorsOxidation-ReductionTumor Microenvironment

Stichwörter der Autor:innen

PD-L1autophagic cell deathchemo-immunotherapynuclear targetingredox-trigger nanoplatform

Substanzen

B7-H1 AntigenCD274 protein, humanHyaluronic AcidImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
  • College of Biomedical Engineering, Sichuan University, 29 Wangjiang Road, Chengdu, Sichuan 610064, China.
  • Sichuan Kelun Pharmaceutical Research Institute Co. Ltd., Chengdu 611130, China.
  • Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266073, China.
  • Department of Clinical Laboratory, No.971 Hospital of the People's Liberation Army Navy, Qingdao 266021, China.

ORCID-Profile: Yujiang Fan, Yan Liang

Förderung

  • Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, M., Zhao, D., Yan, J., Fu, X., Li, F., Liu, G., Fan, Y., Liang, Y., & Zhang, X. (2024). A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy. ACS Nano, 18(20), 12870-12884. https://doi.org/10.1021/acsnano.4c00227

Vancouver

Li M, Zhao D, Yan J, Fu X, Li F, Liu G, et al. A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy. ACS Nano. 2024;18(20):12870-12884. doi:10.1021/acsnano.4c00227

BibTeX
@article{Li2024,
  author = {Li, Ming and Zhao, Dong and Yan, Jianqin and Fu, Xiaoheng and Li, Fashun and Liu, Gecen and Fan, Yujiang and Liang, Yan and Zhang, Xingdong},
  title = {A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {20},
  pages = {12870--12884},
  doi = {10.1021/acsnano.4c00227}
}
Kostenlos starten →